ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Rhinophototherapy May Offer Promise to Allergic Rhinitis Patients

by Heather Lindsey • March 1, 2007

  • Tweet
  • Email
Print-Friendly Version

A form of light treatment called rhinophototherapy is being studied in the United States and may one day provide patients with allergic rhinitis and other diseases of the upper airway, such as nasal polyposis, with an alternative to standard therapies.

You Might Also Like

  • Dissonance Between Patients’ and Physicians’ Perceptions of Allergic Rhinitis and Effects of Medications
  • Another Option for Allergic Rhinitis?: Study examines long-term safety, efficacy of RF turbinoplasty
  • SCIT Effective for Asthma, Allergic Rhinitis
  • Improving Quality of Life for Allergic and Nonallergic Rhinitis Patients
Explore This Issue
March 2007

The technology is being developed at Allux Medical in Menlo Park, Calif., to treat hyper-reactive airway mucosa. According to company president and CEO Erica Rogers, the first application of rhinophototherapy may be for allergic rhinitis, although the technology has not yet been approved by the Food and Drug Administration and no therapeutic devices are currently available in the United States.

The experts interviewed for this article agreed that although the technology is intriguing, further research is needed to establish long-term efficacy and safety.

How It Works

The therapy uses a combination of UV-B (5%), UV-A (25%), and visible light (70%), which practitioners shine directly into the intranasal cavity.

We believe it works through a mechanism similar to that of light therapy used for patients with dermatological diseases such as atopic dermatitis and eczema, said James Hadley, MD, Associate Professor of Otolaryngology at the University of Rochester Medical Center. Light therapy induces apoptosis of the inflammatory cells in the organ-whether the skin or nasal mucosa-that cause disease symptoms, he said.

This is an exciting concept that may have potential, commented Bradley F. Marple, MD, Professor and Vice Chairman of Otolaryngology at the University of Texas-Southwestern Medical Center. Most other treatments, with exception of immunotherapy, are directed toward blockage of inflammatory mediators, whereas rhinophototherapy downregulates the cells that generate the allergic response, he said.

Although relatively simple to use, administering the therapy requires physicians to have a background in rhinology and allergic disease management, said Dr. Hadley. Whether they are ENTs, allergists, or family physicians who are trained in this, they need to know the inner workings of nasal anatomy.

The Data

The technology has been studied most extensively in Eastern Europe, where a recent study (J Allergy Clin Immunol 2005;115(3):541-7) indicated strong efficacy in allergic rhinitis patients. The study’s lead author, Andrea I. Koreck, MD, PhD, who at the time was with the Department of Dermatology and Allergology at the University of Szeged in Hungary, is now a researcher at Allux Medical.

Dr. Koreck and her colleagues conducted a randomized, double-blind study during the ragweed season in 49 patients with hay fever who received either rhinophototherapy using a combination of UV-B (5%),UV-A (25%), and visible light (70%), referred to as mUV/VIS, or low-intensity visible light as a control.

Pages: 1 2 3 4 | Single Page

Filed Under: Articles, Clinical, Features Issue: March 2007

You Might Also Like:

  • Dissonance Between Patients’ and Physicians’ Perceptions of Allergic Rhinitis and Effects of Medications
  • Another Option for Allergic Rhinitis?: Study examines long-term safety, efficacy of RF turbinoplasty
  • SCIT Effective for Asthma, Allergic Rhinitis
  • Improving Quality of Life for Allergic and Nonallergic Rhinitis Patients

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Vertigo in the Elderly: What Does It Mean?
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.